Cargando…

An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination

To determine the degree of cancer cell killing after treatment with chemotherapeutic drugs, we have developed a sensitive platform using localized surface plasmon resonance (LSPR) and aptamers to detect the extracellular cytochrome-c (cyto-c), a mitochondrial protein released from cancer cells for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Loo, Jacky Fong-Chuen, Lau, Pui-Man, Kong, Siu-Kai, Ho, Ho-Pui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190337/
https://www.ncbi.nlm.nih.gov/pubmed/30400530
http://dx.doi.org/10.3390/mi8110338
_version_ 1783363546774503424
author Loo, Jacky Fong-Chuen
Lau, Pui-Man
Kong, Siu-Kai
Ho, Ho-Pui
author_facet Loo, Jacky Fong-Chuen
Lau, Pui-Man
Kong, Siu-Kai
Ho, Ho-Pui
author_sort Loo, Jacky Fong-Chuen
collection PubMed
description To determine the degree of cancer cell killing after treatment with chemotherapeutic drugs, we have developed a sensitive platform using localized surface plasmon resonance (LSPR) and aptamers to detect the extracellular cytochrome-c (cyto-c), a mitochondrial protein released from cancer cells for the induction of apoptosis after treatment, to evaluate the effectiveness of cancer therapy. In this assay, a short single-stranded 76-mer DNA aptamer with a unique DNA sequence, which binds towards the cyto-c like an antibody with a high binding affinity and specificity, was conjugated to gold nanorods (AuNR) for LSPR sensing. Practically, cyto-c was first grabbed by a capturing antibody functionalized on the surface of micro-magnetic particles (MMPs). Subsequently, the AuNR-conjugated aptamer was added to form a complex sandwich structure with cyto-c (i.e., (MMP-Ab)-(cyto-c)-(AuNR-aptamer)) after washing away the non-target impurities, such as serum residues and intracellular contents, in a microfluidic chip. The sandwich complex led to formation of AuNR aggregates, which changed the LSPR signals in relation to the amount of cyto-c. With the LSPR signal enhancement effects from the AuNRs, the detection limit of cyto-c, sparked in human serum or culture medium, was found to be 0.1 ng/mL in our platform and the whole sensing process could be completed within two hours. Moreover, we have applied this assay to monitor the apoptosis in leukemia cancer cells induced by a potential anti-cancer agent phenylarsine oxide.
format Online
Article
Text
id pubmed-6190337
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61903372018-11-01 An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination Loo, Jacky Fong-Chuen Lau, Pui-Man Kong, Siu-Kai Ho, Ho-Pui Micromachines (Basel) Article To determine the degree of cancer cell killing after treatment with chemotherapeutic drugs, we have developed a sensitive platform using localized surface plasmon resonance (LSPR) and aptamers to detect the extracellular cytochrome-c (cyto-c), a mitochondrial protein released from cancer cells for the induction of apoptosis after treatment, to evaluate the effectiveness of cancer therapy. In this assay, a short single-stranded 76-mer DNA aptamer with a unique DNA sequence, which binds towards the cyto-c like an antibody with a high binding affinity and specificity, was conjugated to gold nanorods (AuNR) for LSPR sensing. Practically, cyto-c was first grabbed by a capturing antibody functionalized on the surface of micro-magnetic particles (MMPs). Subsequently, the AuNR-conjugated aptamer was added to form a complex sandwich structure with cyto-c (i.e., (MMP-Ab)-(cyto-c)-(AuNR-aptamer)) after washing away the non-target impurities, such as serum residues and intracellular contents, in a microfluidic chip. The sandwich complex led to formation of AuNR aggregates, which changed the LSPR signals in relation to the amount of cyto-c. With the LSPR signal enhancement effects from the AuNRs, the detection limit of cyto-c, sparked in human serum or culture medium, was found to be 0.1 ng/mL in our platform and the whole sensing process could be completed within two hours. Moreover, we have applied this assay to monitor the apoptosis in leukemia cancer cells induced by a potential anti-cancer agent phenylarsine oxide. MDPI 2017-11-22 /pmc/articles/PMC6190337/ /pubmed/30400530 http://dx.doi.org/10.3390/mi8110338 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Loo, Jacky Fong-Chuen
Lau, Pui-Man
Kong, Siu-Kai
Ho, Ho-Pui
An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
title An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
title_full An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
title_fullStr An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
title_full_unstemmed An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
title_short An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
title_sort assay using localized surface plasmon resonance and gold nanorods functionalized with aptamers to sense the cytochrome-c released from apoptotic cancer cells for anti-cancer drug effect determination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190337/
https://www.ncbi.nlm.nih.gov/pubmed/30400530
http://dx.doi.org/10.3390/mi8110338
work_keys_str_mv AT loojackyfongchuen anassayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT laupuiman anassayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT kongsiukai anassayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT hohopui anassayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT loojackyfongchuen assayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT laupuiman assayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT kongsiukai assayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination
AT hohopui assayusinglocalizedsurfaceplasmonresonanceandgoldnanorodsfunctionalizedwithaptamerstosensethecytochromecreleasedfromapoptoticcancercellsforanticancerdrugeffectdetermination